Author

Todd D Molfenter

University of Wisconsin - Cited by 2,053 - Implementation Science - Organizational Change - Payer Policy

Biography

Todd D Molfenter is University Avenue Madison.Center for Health Enhancement Systems Studies (CHESS), Mechanical Engineering Building. Research Interest :Medication adherence; Physician-patient communication; Family hardiness,epidemiology, pathogenesis, Adolescent medicine, Diabetes mellitus, Metabolic syndrome, Nonsurgical Treatment, Immunology infectious diseases, Clinical immunology, Hypertension, Multi-system disease.
Title
Cited by
Year
Trends in telemedicine use in addiction treatment
T Molfenter, M Boyle, D Holloway, J ZwickAddiction science & clinical practice 10, 1-9, 2015201
131
2015
Implementing buprenorphine in addiction treatment: payer and provider perspectives in Ohio
T Molfenter, C Sherbeck, M Zehner, A Quanbeck, D McCarty, JS Kim, ...Substance abuse treatment, prevention, and policy 10, 1-10, 2015201
62
2015
Use of telehealth in substance use disorder services during and after COVID-19: online survey study
T Molfenter, N Roget, M Chaple, S Behlman, O Cody, B Hartzler, ...JMIR mental health 8 (2), e25835, 2021202
54
2021
Use of telemedicine in addiction treatment: current practices and organizational implementation characteristics
T Molfenter, R Brown, A O’Neill, E Kopetsky, A ToyInternational Journal of Telemedicine and Applications 2018, 2018201
44
2018
Use of telehealth in mental health (MH) services during and after COVID-19
T Molfenter, T Heitkamp, AA Murphy, S Tapscott, S Behlman, OJ CodyCommunity Mental Health Journal 57 (7), 1244-1251, 2021202
41
2021
Barriers to buprenorphine expansion in Ohio: a time-elapsed qualitative study
T Molfenter, M Fitzgerald, N Jacobson, D McCarty, A Quanbeck, M ZehnerJournal of psychoactive drugs 51 (3), 272-279, 2019201
32
2019
Buprenorphine prescribing availability in a sample of Ohio specialty treatment organizations
T Molfenter, C Sherbeck, M Zehner, S StarrJournal of addictive behaviors, therapy & rehabilitation 4 (2), 2015201
19
2015
Reducing psychiatric inpatient readmissions using an organizational change model
T Molfenter, T Connor, JH Ford, J Hyatt, D ZimmermanWmj 115 (3), 122-8, 2016201
19
2016
Proceedings from the 9th annual conference on the science of dissemination and implementation: Washington, DC, USA. 14-15 December 2016
D Chambers, L Simpson, G Neta, UT Schwarz, A Percy-Laurry, ...Implementation Science 12, 1-55, 201717201
17
2017
Test of a workforce development intervention to expand opioid use disorder treatment pharmacotherapy prescribers: protocol for a cluster randomized trial
T Molfenter, HK Knudsen, R Brown, N Jacobson, J Horst, M Van Etten, ...Implementation Science 12 (1), 1-9, 2017201
15
2017
Organizational facilitators and barriers to medication for opioid use disorder capacity expansion and use
N Jacobson, J Horst, L Wilcox-Warren, A Toy, HK Knudsen, R Brown, ...The journal of behavioral health services & research 47, 439-448, 2020202
13
2020
The pressing shortage of buprenorphine prescribers and the pending role of telemedicine
T MolfenterAddiction Science & Clinical Practice (1), 1-2, 2015201
10
2015
Physicians’ satisfaction with providing buprenorphine treatment
HK Knudsen, R Brown, N Jacobson, J Horst, JS Kim, E Collier, S Starr, ...Addiction Science & Clinical Practice 14 (1), 1-7, 2019201
10
2019
Pharmacotherapy, resource needs, and physician recruitment practices in substance use disorder treatment programs
HK Knudsen, R Brown, N Jacobson, J Horst, JS Kim, E Collier, S Starr, ...Journal of addiction medicine 13 (1), 28, 20120
9
2019
Sustaining gains in diabetic eye screening: outcomes from a stakeholder-based implementation program for teleophthalmology in primary care
Y Liu, JN Carlson, A Torres Diaz, LJ Lock, NJ Zupan, TD Molfenter, ...Telemedicine and e-Health 27 (9), 1021-102, 2021202
8
2021
Influence of environmental design on team interactions across three family medicine clinics: perceptions of communication, efficiency, and privacy
Z Karp, S Kamnetz, N Wietfeldt, C Sinsky, T Molfenter, N PandhiHERD: Health Environments Research & Design Journal 12 (4), 159-173, 2019201
8
2019
Well-being of health care professionals treating opioid use disorder during the COVID-19 pandemic: Results from a national survey
D Blevins, BF Henry, M Sung, EJ Edelman, AC Black, M Dawes, ...Psychiatric Services 73 (4), 374-30, 2022202
8
2022
Payer policy behavior towards opioid pharmacotherapy treatment in Ohio
T Molfenter, C Sherbeck, S Starr, JS Kim, M Zehner, A Quanbeck, ...Journal of addiction medicine 12 (2), 8, 2018201
5
2018
Fostering MOUD use in justice populations: assessing the comparative effectiveness of two favored implementation strategies to increase MOUD use
T Molfenter, J Vechinski, FS Taxman, AJ Breno, CC Shaw, HA PerezJournal of Substance Abuse Treatment 128, 108370, 2021202
4
2021
Shortages of medication-assisted treatment for opioid use disorder in underserved Michigan counties: examining the influence of urbanicity and income level
JJ Lister, A Weaver, JD Ellis, T Molfenter, DM Ledgerwood, JA HimleJournal of Health Care for the Poor and Underserved 1 (), 1291-107, 2020202
3
2020

Referred From: https://scholar.google.com/citations?user=x2haLbwAAAAJ

Cited by
Citations 2053
h-index 19
i10-index 31
Open Access Journals